XGene Regulatory Intelligence Platform
Browse structured XGene intelligence and connected implementation resources.
XGene’s role can extend beyond document preparation. A strong regulatory response or CMC dossier depends on the quality of the […]
View details →The process begins with an initial consultation to clarify the problem, affected product or system, regulatory context, urgency, available evidence, […]
View details →XGene’s service scope is relevant to both development-stage sponsors and established pharmaceutical or life-sciences organizations. Early-stage companies may need help […]
View details →A meeting is most useful when the sponsor can clearly define the decision needed, the evidence already available, the remaining […]
View details →The appropriate use depends on the level of regulatory maturity and human oversight. Established applications include tools supporting process monitoring, […]
View details →AI readiness begins with information governance, not document generation. CMC knowledge should be managed as controlled, traceable data objects with […]
View details →The QOS should function as a scientific argument, not merely repeat Module 3 headings. It should connect the Quality Target […]
View details →A narrow Part 11-style review can miss several operational controls emphasized by Annex 11. Companies should evaluate supplier assessment and […]
View details →Audit-trail review is only one control within a broader data-governance system. A credible remediation program may need to define the […]
View details →CAPA closure is an administrative status showing that assigned actions were completed. Effectiveness is an evidence-based conclusion that the actions […]
View details →